FLT3	SUNITINIB	multitarget	DrugBank	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SORAFENIB	antagonist	DrugBank	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB	n/a	TEND	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SORAFENIB	n/a	TEND	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	MIDOSTAURIN	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB MALATE	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	TANDUTINIB	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	4SC-203	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SU5614	inhibitor	TTD	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	QUIZARTINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	PONATINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	AS703569	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	LESTAURTINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	ENMD-0276	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	TANDUTINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	AMUVATINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	MIDOSTAURIN	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	PLX3397	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	CABOZANTINIB	inhibitor	MyCancerGenome	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	PLX108-01	inhibitor	CancerCommons	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	PLX3397	inhibitor	CancerCommons	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SORAFENIB	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	XL999	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	AMUVATINIB	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	ENMD-0276	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	AS703569	inhibitor	TALC	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	AZACITIDINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SORAFENIB TOSYLATE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	BORTEZOMIB	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	CLOFARABINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	4'-N-BENZOYLSTAUROSPORINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	4'-N-BENZOYLSTAUROSPORINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	IDARUBICINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SORAFENIB TOSYLATE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	4'-N-BENZOYLSTAUROSPORINE	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	CRENOLANIB	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	CRENOLANIB	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
FLT3	SUNITINIB	inhibitor	MyCancerGenomeClinicalTrial	cell surface,clinically actionable,druggable genome,kinase,tyrosine kinase
